SureTrader Advertisement SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, noretreat, TOB, sox040713, TheHound
Search This Board:
Last Post: 4/30/2016 12:33:30 AM - Followers: 695 - Board type: Free - Posts Today: 1

Cellceutix Corporation (CTIX)
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


The above link is kept updated.

Ongoing Human Trials:
Product Pipeline:


Recent News and Press Releases:

Seeking Alpha focus articles on CTIX:

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

SEC Filings:

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Current Report Filing (8-k) 04/08/2016 10:04:54 AM
CTIX News: Current Report Filing (8-k) 03/31/2016 06:24:52 AM
CTIX News: Quarterly Report (10-q) 02/08/2016 04:03:50 PM
CTIX News: Amended Statement of Ownership (sc 13g/a) 01/27/2016 09:57:11 AM
CTIX News: Small Cap Stocks Are Heating up Again, Small Cap Street is Covering (OTCQB: ELTP),(OTCBB: AHIX), (OTCBB: AXXE), (OTCBB: CTIX) 01/26/2016 07:40:00 AM
#145433  Sticky Note Simply Cellceutix; BooDog 04/19/16 08:25:26 PM
#144297  Sticky Note CTIX Potential Catalysts and Past Milestones sox040713 04/04/16 06:21:44 PM
#144039  Sticky Note $CTIX ---> (.)(.) <--- CTIX$ TheHound 03/31/16 03:44:16 PM
#139659  Sticky Note (repost) Court Filings (Zagami vs Cellceutix, 1:15-cv-07194) slcimmuno 02/11/16 08:25:42 AM
#133344  Sticky Note We are looking forward ... to our fiscal noretreat 12/14/15 02:58:59 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#146251   Next week will be quite interesting. We have septmike09 04/30/16 12:33:30 AM
#146249   ovarian cancer drug market will more than CallMeCrazy 04/29/16 07:44:18 PM
#146247   FINRA short sales of CTIX AlanC 04/29/16 07:13:40 PM
#146245   "The article Sox posted misquoted the article they loanranger 04/29/16 05:44:14 PM
#146244   Anyone paying for these reports couldn't fact check Phteven C 04/29/16 05:42:02 PM
#146243   First, "Ovarian cancer is the seventh most common Phteven C 04/29/16 05:41:10 PM
#146241   It's hard to believe an article could be loanranger 04/29/16 05:15:15 PM
#146240   Incorrect information. First, "Ovarian cancer is the seventh BigKahuna 04/29/16 05:03:53 PM
#146239   IMO, last day of stealth accumulation with under BigKahuna 04/29/16 04:50:39 PM
#146238   Be more conservative and it's an even more Phteven C 04/29/16 04:46:52 PM
#146237   Thanks for pointing out the mistake. If Kevetrin sox040713 04/29/16 04:42:24 PM
#146236   The article Sox posted misquoted the article they Phteven C 04/29/16 04:21:59 PM
#146235   Jewish holiday ends today. Next week I'm thinking BooDog 04/29/16 04:12:21 PM
#146234   someone wanted in before monday! cascott 04/29/16 04:08:40 PM
#146233   bullish! TheHound 04/29/16 04:04:31 PM
#146232   $1.84 ask slapping... :) Have a ericseb2003 04/29/16 03:58:28 PM
#146231   HOD close headed our way. TheHound 04/29/16 03:50:41 PM
#146230   Kevetrin is also mentioned in this article. sox040713 04/29/16 03:03:51 PM
#146229   Thanks SOX ! wild4ctix 04/29/16 03:02:35 PM
#146228   Thanks for that sox!! cabel 04/29/16 02:49:53 PM
#146227   "ovarian cancer drug market would garner $111.9 billion DaubersUP 04/29/16 02:49:09 PM
#146226   Boom!! DaubersUP 04/29/16 02:41:55 PM
#146225   LOL, glad to see the SP ran up sox040713 04/29/16 02:40:21 PM
#146224   Only stocks up today. AMZN and CTIX. Great company. septmike09 04/29/16 02:38:44 PM
#146223   You could be right. We have 1:37:00 left TheDane 04/29/16 02:23:30 PM
#146222   Thanks for posting. Can't wait for more news Jhawker 04/29/16 01:37:01 PM
#146221   volume is thin, they won't sell cascott 04/29/16 01:06:03 PM
#146220   This stock can't hold losses, Ha ha ha! rule_rationale 04/29/16 01:04:07 PM
#146219   beautiful - thanks poonch1ne 04/29/16 12:59:54 PM
#146218   FDA finally speeds up approval for ovarian cancer drugs sox040713 04/29/16 12:57:34 PM
#146217   Unless there is some short covering at the septmike09 04/29/16 12:46:51 PM
#146216   More like a block of concrete. septmike09 04/29/16 12:29:58 PM
#146215   Why would anyone expect news on P today? ACanJadaS 04/29/16 11:58:41 AM
#146214   so much for a friday surprise with P news To infinity and beyond! 04/29/16 11:57:09 AM
#146213   Yeah, I'm thinking it gets into the 1.90s hazelhurst 04/29/16 11:46:12 AM
#146212   CTIX has been holding well at this level redwing992006 04/29/16 11:42:37 AM
#146211   Here's your chance to sell that block at $1.82. sox040713 04/29/16 11:33:46 AM
#146209   Sorry to disappoint, but the stock is up again. DoubleJ23 04/29/16 11:20:40 AM
#146208   I'm calling 1.90's today....looks ready to go up dmsrz8 04/29/16 11:04:31 AM
#146207   Thanks for your input...... incubus-now 04/29/16 10:57:02 AM
#146206   Forgot to add, likely we are in the I Need Help 04/29/16 10:38:42 AM
#146205   yep - stock is trading very heavy. MXAMDUD 04/29/16 10:19:50 AM
#146204   Looking on the daily chart, which is probably I Need Help 04/29/16 10:19:41 AM
#146203   Thanks Karin, TGIF. Looks like a very vip1999 04/29/16 09:54:43 AM
#146202   Wouldn't it be nice... To infinity and beyond! 04/29/16 09:44:01 AM
#146201   Much appreciated!! cabel 04/29/16 09:40:47 AM
#146200   Cabel, sorry, didn't get to read the board ericseb2003 04/29/16 09:36:24 AM
#146199   I'd put it at about 1M because any I Need Help 04/29/16 09:13:07 AM
#146198   Thanks KarinCA. "Liked" your comment. Detonate 04/29/16 09:02:22 AM
#146197   Certainly hope and believe they will be. Thanks bradfordbros 04/29/16 08:47:16 AM